Time Restricted Eating vs. Caloric Restriction for Obesity
(Time2Eat Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The trial aims to explore how different eating schedules aid weight loss in adults with obesity. It compares early and late time-restricted eating (intermittent fasting) with traditional calorie counting (daily caloric restriction) to determine which approach more effectively promotes weight loss and improves metabolic health. Participants will follow one of these eating plans for a year. This trial suits adults with a BMI between 27 and 45 who are not currently practicing intermittent fasting or similar diets and live near the Anschutz Health & Wellness Center. As an unphased trial, it offers participants the chance to contribute to innovative research that could shape future dietary guidelines.
Will I have to stop taking my current medications?
The trial does not specify if you must stop taking your current medications, but it excludes those who have taken medications affecting weight or energy in the last 6 months. If your medication must be taken with food, it may depend on whether it can be adjusted to fit the eating schedule of the study.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that time-restricted eating (TRE), whether early or late in the day, is generally safe for people with obesity. Studies indicate that TRE can aid weight loss and improve insulin levels and body composition. Specifically, early TRE has led to improvements in blood pressure and mood. Late TRE has also resulted in modest weight loss and positive changes in body fat and waist size.
Although some studies have demonstrated successful weight loss with TRE, they report no major changes in blood sugar levels, suggesting that this approach is well-tolerated. These studies report no serious side effects, indicating that both types of TRE are safe for improving weight and metabolic health.12345Why are researchers excited about this trial's treatments?
Researchers are excited about this trial because it's exploring new ways to tackle obesity through time-restricted eating (TRE) and caloric restriction. Unlike traditional methods that focus solely on cutting calories, TRE involves eating within specific time windows, either early or late in the day, potentially aligning better with our natural body rhythms. This approach may offer benefits like improved metabolism or reduced hunger, making weight management more sustainable. By comparing early and late TRE with daily caloric restriction, researchers aim to understand which method is most effective and why, potentially paving the way for more personalized and flexible obesity treatments.
What evidence suggests that this trial's treatments could be effective for obesity?
This trial will compare early time-restricted eating (eTRE), late time-restricted eating (late TRE), and daily caloric restriction (DCR) for obesity. Research has shown that eating within a limited time early in the day (eTRE) can aid weight loss and improve health. Studies indicate that eTRE is more effective for losing weight and improving factors like blood pressure and mood compared to eating over a longer period. Participants following eTRE have lost about 3%–5% of their weight over several months.
For eating later in the day (late TRE), evidence suggests it also aids in weight loss and can improve insulin levels. One study found that late TRE led to noticeable improvements in body composition and health markers. Both early and late TRE are promising for weight loss, with early TRE showing slightly better results in some studies. Participants in this trial will be assigned to one of these approaches to evaluate their effectiveness in weight management.26789Are You a Good Fit for This Trial?
Adults aged 18-65 with obesity (BMI of 27-45 kg/m2) who typically eat over a span of more than 12 hours daily, own a smartphone, and can commit to the trial for one year without relocating. They must pass medical screenings and be willing to give informed consent.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants follow assigned dietary strategy (early TRE, late TRE, or daily caloric restriction) for 1 year with group-based program for instruction and support
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- DCR
- Early TRE
- Late TRE
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Colorado, Denver
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator